These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 12324469)
1. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. Latz E; Visintin A; Lien E; Fitzgerald KA; Monks BG; Kurt-Jones EA; Golenbock DT; Espevik T J Biol Chem; 2002 Dec; 277(49):47834-43. PubMed ID: 12324469 [TBL] [Abstract][Full Text] [Related]
2. Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. Visintin A; Latz E; Monks BG; Espevik T; Golenbock DT J Biol Chem; 2003 Nov; 278(48):48313-20. PubMed ID: 12960171 [TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. da Silva Correia J; Soldau K; Christen U; Tobias PS; Ulevitch RJ J Biol Chem; 2001 Jun; 276(24):21129-35. PubMed ID: 11274165 [TBL] [Abstract][Full Text] [Related]
4. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. da Silva Correia J; Ulevitch RJ J Biol Chem; 2002 Jan; 277(3):1845-54. PubMed ID: 11706042 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of CD14, TLR4, and MD-2 in HEK 293T cells does not prevent induction of in vitro endotoxin tolerance. Medvedev AE; Vogel SN J Endotoxin Res; 2003; 9(1):60-4. PubMed ID: 12691621 [TBL] [Abstract][Full Text] [Related]
7. A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4. Kennedy MN; Mullen GE; Leifer CA; Lee C; Mazzoni A; Dileepan KN; Segal DM J Biol Chem; 2004 Aug; 279(33):34698-704. PubMed ID: 15175334 [TBL] [Abstract][Full Text] [Related]
8. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling. Hyakushima N; Mitsuzawa H; Nishitani C; Sano H; Kuronuma K; Konishi M; Himi T; Miyake K; Kuroki Y J Immunol; 2004 Dec; 173(11):6949-54. PubMed ID: 15557191 [TBL] [Abstract][Full Text] [Related]
10. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88. Dunne A; Ejdeback M; Ludidi PL; O'Neill LA; Gay NJ J Biol Chem; 2003 Oct; 278(42):41443-51. PubMed ID: 12888566 [TBL] [Abstract][Full Text] [Related]
11. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. Medvedev AE; Lentschat A; Wahl LM; Golenbock DT; Vogel SN J Immunol; 2002 Nov; 169(9):5209-16. PubMed ID: 12391239 [TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. Akashi S; Saitoh S; Wakabayashi Y; Kikuchi T; Takamura N; Nagai Y; Kusumoto Y; Fukase K; Kusumoto S; Adachi Y; Kosugi A; Miyake K J Exp Med; 2003 Oct; 198(7):1035-42. PubMed ID: 14517279 [TBL] [Abstract][Full Text] [Related]
13. Induction of bacterial lipoprotein tolerance is associated with suppression of toll-like receptor 2 expression. Wang JH; Doyle M; Manning BJ; Di Wu Q; Blankson S; Redmond HP J Biol Chem; 2002 Sep; 277(39):36068-75. PubMed ID: 12133836 [TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic domain-mediated dimerizations of toll-like receptor 4 observed by beta-lactamase enzyme fragment complementation. Lee HK; Dunzendorfer S; Tobias PS J Biol Chem; 2004 Mar; 279(11):10564-74. PubMed ID: 14699116 [TBL] [Abstract][Full Text] [Related]
15. Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Vives-Pi M; Somoza N; Fernández-Alvarez J; Vargas F; Caro P; Alba A; Gomis R; Labeta MO; Pujol-Borrell R Clin Exp Immunol; 2003 Aug; 133(2):208-18. PubMed ID: 12869026 [TBL] [Abstract][Full Text] [Related]
16. The amino-terminal region of toll-like receptor 4 is essential for binding to MD-2 and receptor translocation to the cell surface. Fujimoto T; Yamazaki S; Eto-Kimura A; Takeshige K; Muta T J Biol Chem; 2004 Nov; 279(46):47431-7. PubMed ID: 15337750 [TBL] [Abstract][Full Text] [Related]
17. N-linked glycosylations at Asn(26) and Asn(114) of human MD-2 are required for toll-like receptor 4-mediated activation of NF-kappaB by lipopolysaccharide. Ohnishi T; Muroi M; Tanamoto K J Immunol; 2001 Sep; 167(6):3354-9. PubMed ID: 11544325 [TBL] [Abstract][Full Text] [Related]
18. The extra domain A of fibronectin activates Toll-like receptor 4. Okamura Y; Watari M; Jerud ES; Young DW; Ishizaka ST; Rose J; Chow JC; Strauss JF J Biol Chem; 2001 Mar; 276(13):10229-33. PubMed ID: 11150311 [TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. Jiang Q; Akashi S; Miyake K; Petty HR J Immunol; 2000 Oct; 165(7):3541-4. PubMed ID: 11034352 [TBL] [Abstract][Full Text] [Related]